Pretransplant MELD score and post liver transplantation survival in the UK and Ireland.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 15237375)

Published in Liver Transpl on July 01, 2004

Authors

Mathew Jacob1, Lynn P Copley, James D Lewsey, Alex Gimson, Giles J Toogood, Mohamed Rela, Jan H P van der Meulen, UK and Ireland Liver Transplant Audit

Author Affiliations

1: Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK. mjacob@rcseng.ac.uk

Articles citing this

Geographic inequity in access to livers for transplantation. Transplantation (2011) 1.71

Survival after liver transplantation in the United Kingdom and Ireland compared with the United States. Gut (2007) 1.51

The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation. J Gastroenterol (2006) 1.47

Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05

Life expectancy of adult liver allograft recipients in the UK. Gut (2006) 0.91

The evolution in the prioritization for liver transplantation. Ann Gastroenterol (2012) 0.87

Analyses of prognostic indices of chronic liver failure caused by hepatitis virus. World J Gastroenterol (2005) 0.85

Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open (2013) 0.83

Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience. HPB (Oxford) (2015) 0.82

Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30. Langenbecks Arch Surg (2011) 0.82

Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients. Clinics (Sao Paulo) (2015) 0.81

Adult Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure in High- Model for End-Stage Liver Disease Score Patients. Am J Transplant (2017) 0.80

Incidence and Outcomes of Acute Renal Failure Following Liver Transplantation: A Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.79

Is SAPS 3 better than APACHE II at predicting mortality in critically ill transplant patients? Clinics (Sao Paulo) (2013) 0.79

The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients. BMC Anesthesiol (2014) 0.78

Allocation of donor livers--is MELD enough? Liver Transpl (2004) 0.78

Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantation. Can J Surg (2011) 0.76

Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B. World J Gastroenterol (2008) 0.76

Living donor liver transplantation for high model for end-stage liver disease score: What have we learned? World J Hepatol (2016) 0.75

Predictive factors of short term outcome after liver transplantation: A review. World J Gastroenterol (2016) 0.75

Articles by these authors

Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation (2009) 2.60

Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Mathematical coupling may account for the association between baseline severity and minimally important difference values. J Clin Epidemiol (2010) 1.99

Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol (2008) 1.64

Right hepatic trisectionectomy for hepatobiliary diseases: results and an appraisal of its current role. Ann Surg (2007) 1.62

One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62

A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin. BJU Int (2004) 1.60

Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58

The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl (2007) 1.52

Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg (2004) 1.49

Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47

Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47

Developing a prognostic model for 90-day mortality after liver transplantation based on pretransplant recipient factors. Transplantation (2006) 1.46

Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg (2010) 1.45

Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45

Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45

Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43

A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection. Ann R Coll Surg Engl (2009) 1.42

Outcomes in right liver lobe transplantation: a matched pair analysis. Transpl Int (2008) 1.40

Live organ-donation for islet transplantation. Lancet (2005) 1.40

Revision rates after primary hip and knee replacement in England between 2003 and 2006. PLoS Med (2008) 1.36

Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg (2007) 1.35

Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol (2007) 1.31

Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25

Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg (2003) 1.20

Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18

Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15

The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15

Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. J Neurol Neurosurg Psychiatry (2010) 1.13

Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl (2009) 1.13

Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13

Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12

Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10

Pseudoaneurysm following laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2007) 1.10

Centralisation of services for children with cleft lip or palate in England: a study of hospital episode statistics. BMC Health Serv Res (2012) 1.10

Emergency liver transplantation following severe liver trauma. Liver Transpl (2008) 1.09

Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology (2005) 1.09

Mortality in men admitted to hospital with acute urinary retention: database analysis. BMJ (2007) 1.08

Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int (2007) 1.08

Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary Pancreat Dis Int (2010) 1.07

Inferior vena cava resection with hepatectomy: challenging but justified. HPB (Oxford) (2011) 1.06

Systematic review and validation of prognostic models in liver transplantation. Liver Transpl (2005) 1.06

Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation (2003) 1.06

Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl (2004) 1.04

Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation (2009) 1.04

Outcomes after major hepatectomy in elderly patients. J Am Coll Surg (2006) 1.03

Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg (2005) 1.01

Graft positioning at liver transplantation in situs inversus. Liver Transpl (2006) 1.01

Adult orthotopic liver transplantation in the United Kingdom and Ireland between 1994 and 2005. Transplantation (2007) 1.00

Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant (2003) 1.00

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care (2010) 1.00

Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol (2008) 0.99

Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci (2009) 0.99

Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl (2010) 0.98

Auxiliary liver transplantation for acute liver failure in children. Ann Surg (2010) 0.98

Bile duct strictures after hepatobiliary surgery: assessment with MR cholangiography. Radiology (2004) 0.98

Treatment and surveillance of polypoid lesions of the gallbladder in the United Kingdom. HPB (Oxford) (2012) 0.97

An analysis of the Research Fellowship Scheme of the Royal College of Surgeons of England. J Am Coll Surg (2005) 0.97

Hydrodynamic gene delivery to the liver: theoretical and practical issues for clinical application. Curr Gene Ther (2009) 0.97

Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences. Radiology (2003) 0.97

Evidence for the presence of stem cell-like progenitor cells in human adult pancreas. J Endocrinol (2007) 0.96

Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation (2006) 0.96

Index admission laparoscopic cholecystectomy for patients with acute biliary symptoms: results from a specialist centre. HPB (Oxford) (2010) 0.96

Results of split liver transplantation in children. Ann Surg (2002) 0.96

Laparoscopic versus open left lateral segmentectomy. BMC Surg (2009) 0.96

Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations. Indian J Gastroenterol (2014) 0.95

Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells. PLoS One (2008) 0.94

Auxiliary transplantation for acute liver failure: Histopathological study of native liver regeneration. Liver Transpl (2008) 0.94

Bile duct strictures after adult liver transplantation: a role for biliary reconstructive surgery? Liver Transpl (2004) 0.94

The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology (2003) 0.94

Patient views through the keyhole: new perspectives on single-incision vs. multiport laparoscopic cholecystectomy. HPB (Oxford) (2012) 0.94

Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford) (2007) 0.94

Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl (2013) 0.93

Resection of liver metastases from breast cancer: towards a management guideline. Int J Surg (2011) 0.93

Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics. BMJ Open (2013) 0.93

Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg (2005) 0.93

Pancreatic trauma--12-year experience from a tertiary center. Pancreas (2009) 0.92

Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. J Am Coll Surg (2011) 0.91

Liver transplantation for acute intermittent porphyria: a viable treatment? Hepatobiliary Pancreat Dis Int (2010) 0.91

Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique. Lab Invest (2005) 0.91

Cancer of the uncinate process of the pancreas: surgical anatomy and clinicopathological features. Hepatobiliary Pancreat Dis Int (2009) 0.91

Diaphragmatic hernia after liver transplantation in children: case series and review of the literature. Liver Transpl (2014) 0.90

Controversies in the management of borderline resectable proximal pancreatic adenocarcinoma with vascular involvement. HPB Surg (2009) 0.90

Hepatic solitary fibrous tumor: report of a rare case. Indian J Pathol Microbiol (2012) 0.90

Renal biopsy in liver transplant recipients. Nephrol Dial Transplant (2009) 0.90

Utility of drain fluid amylase measurement on the first postoperative day after pancreaticoduodenectomy. World J Surg (2012) 0.90

Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg (2007) 0.89

Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg (2008) 0.89

Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial. Eur J Heart Fail (2010) 0.89

N-acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue. Cell Transplant (2010) 0.89

Predictors of blood transfusion requirement in elective liver resection. HPB (Oxford) (2010) 0.88

Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circ Heart Fail (2008) 0.88

Xanthogranulomatous cholecystitis: a European and global perspective. HPB (Oxford) (2013) 0.87

Two distinct pathways of carcinogenesis in primary sclerosing cholangitis. Histopathology (2011) 0.87

One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg (2014) 0.87

Acceptable outcome after kidney transplantation using "expanded criteria donor" grafts. Transplantation (2010) 0.87